Brief: Epigenomics Implements Measures To Reduce Costs During COVID-19 Pandemic
14/04/2020 07:06
April 14 (Reuters) - EPIGENOMICS AG ECXn.DE :
* IMPLEMENTS COMPREHENSIVE MEASURES TO REDUCE COSTS DURING
COVID-19 PANDEMIC CRISIS
* COMPANY HAS REDUCED EXPENSES ACROSS ALL AREAS OF BUSINESS
DURING
THIS UNPRECEDENTED TIME INCLUDING PAYROLL IN BOTH GERMANY AND
UNITED STATES
Source text for Eikon: ID:nEQ2pkVHYa
Further company coverage: ECXn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns